Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
1 grams -- DF-PE9010
Reconstitution and handling
What is missing There is no published human pharmacokinetic study of subcutaneous AOD-9604, no published human topical or intranasal exposure data, no Phase 3 efficacy trial, no long-term safety data beyond 24 weeks, and no published human cartilage or joint outcome data
On the other hand, IGFBP-3 undergoes augmented proteolysis on diabetic patients which results in a sudden rise of free IGF-1 concentrations [257, 258]
As a multi-dose vial, it can supply multiple injections, making it a practical option for a prescribed treatment plan
Invert slowly or swirl gently until everything dissolves
US$ 25.44
US$ 26.59
US$ 24.95
US$ 22.87
US$ 28.98
